Skip to main content
TOPICS
Videos
Provider
Payer
Pharma
Consumer
Investor
RESOURCES
Events
Jobs
Learning Center
Webinars
White Papers
REGIONS
ANZ
ASIA
EMEA
Global Edition
MORE
About
Advertise
Contact
Privacy Policy
ANZ
ASIA
EMEA
Global Edition
pain management wearable
SPR Therapeutics gains FDA clearance for update to its percutaneous, wearable pain relief platform
By
Dave Muoio
|
12:57 pm |
August 16, 2018
Editor's note: This article has been updated to clarify FDA classification of the Sprint Peripheral Nerve Stinulation system.